CHINA-HI-TECH-FAIR
10.11.2020 16:10:05 CET | Business Wire | Press release
Themed "Transforming Future with Technology, Driving Development with Innovation", the 22nd China High-Tech Fair (CHTF2020) will open on November 11-15, 2020.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201110005830/en/
As the trend-setter of the hi-tech industry, CHTF will provide a glimpse of the future technologies with its “3 Highlights” and “5 Trends”.
Highlight 1: "13th Five-Year" technological achievements
State-level exhibitors including the Ministry of Commerce, the Ministry of Science and Technology, the State Intellectual Property Office, the Chinese Academy of Sciences, and the Ministry of Industry and Information Technology will display technology-related achievements of China’s 13th Five-Year Plan.
Highlight 2: Online show to facilitate overseas exhibitors
Despite the COVID-19 pandemic, 41 countries and international organizations have confirmed to participate in the offline fair, including Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Czech Republic, and Germany. For those who cannot come in person, the “Belt and Road” and International Pavilions will provide online exhibition opportunities.
Highlight 3: Multiple activities to integrate industries, universities and research institutions
CHTF2020 will gather domestic and foreign leading enterprises, technology SMEs, MAKERS, financing institutions, as well as global government officials, entrepreneurs, economists and scholars to discuss policies and make academic exchanges.
Trend 1: AI entering daily life
CHTF2020 will witness more companies embracing "AI + industry". Huawei will bring full-stack, full-scenario solutions and provide development platforms for the governments and enterprises. With a new set of algorithm ecology, channel ecology, and manufacturing ecology, major high-tech companies are making AI technology available to everyone.
Trend 2: Emerging anti-epidemic technologies
CHTF2020 will display new anti-epidemic technologies and products, and their latest applications.
Trend 3: Commercial deployment of 5G
Commercial 5G applications, including 5G smart poles, 5G micro-stations, 5G smart home, and 5G telemedicine will be showcased on the Information Technology and Products Exhibition at Hall 1.
Trend 4: Cutting-edge technologies
About 50 institutes will exhibit at the Pavilion of the Chinese Academy of Sciences.
Trend 5: Smart city
The CHTF Smart City Exhibition will showcase Smart City Ecological Construction, AI Application, 5G, Cloud Computing and Big Data, IoT, Mobile Application and Smart Hardware. Asia-Pacific Smart City Development Summit will also be held.
For more: http://www.chtf.com/english/
View source version on businesswire.com: https://www.businesswire.com/news/home/20201110005830/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Cosylab Launches PlanOne™ Treatment Planning System for Particle Therapy8.6.2026 08:00:00 CEST | Press release
Cosylab today announced the commercial launch of PlanOne™, a treatment planning system for particle therapy, bringing physics-accurate, radiobiologically informed planning and a unified clinical workflow into a single environment. PlanOne™ is FDA 510(k) cleared. "PlanOne™ began with listening. Over the years, our work on control systems in radiation oncology has put us in direct, ongoing contact with medical physicists and clinical teams at some of the leading facilities in the world," said Mark Pleško, CEO of Cosylab. "Our partners have been clear on what matters most for particle therapy: physics accuracy they can defend, clinical confidence at the point of plan approval, and a platform built to grow with AI and adaptive workflows. We designed PlanOne™ around those three priorities, and we'll keep developing it together with the clinical community that helped shape it." Physics-accurate, radiobiologically informed planning PlanOne™ is built on a GPU-accelerated Monte Carlo dose engin
BitGo MENA Launches Regulated Electronic Trading, Delivering Full Suite Trading Services to the Region8.6.2026 06:00:00 CEST | Press release
BitGo MENA FZE (“BitGo MENA”), a subsidiary of BitGo Holdings, Inc. (NYSE: BTGO) (“BitGo”), the digital asset infrastructure company, today announced the launch of electronic trading in the Middle East and North African (MENA). With this launch, clients can now access a comprehensive trading solution combining BitGo MENA’s established over-the-counter (OTC) trading offering with institutional-grade electronic execution, all operating under BitGo MENA’s Broker-Dealer license from Dubai’s Virtual Assets Regulatory Authority (VARA). The launch further expands BitGo MENA’s regulated product suite under VARA’s oversight, marking another step in the region’s continued buildout of institutional digital asset infrastructure amid growing demand for integrated execution and custody solutions. “The Middle East and North Africa has quickly become one of the most exciting regions in the world for digital assets, with regulators, institutions, and innovators moving with real purpose,” said Mike Bels
Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference5.6.2026 18:00:00 CEST | Press release
- ALYFTREK Phase 3 data on children with cystic fibrosis ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including F/F and F/MF shows 65% reached sweat chloride levels of <30 mmol/L; Vertex on track to initiate global regulatory submissions in first half of 2026 - - Long-term 96-week interim analyses from two open-label extension studies demonstrate positive safety and efficacy profile of ALYFTREK in people with cystic fibrosis ages 6 and older -- Phase 3 data on TRIKAFTA® in children 1 to <2 years also presented; Vertex has initiated global regulatory submissions - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating
Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 13:00:00 CEST | Press release
Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built
DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 12:41:00 CEST | Press release
DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom